Pulse Biosciences's market cap is currently ―. The company's EPS TTM is $-1.217; its P/E ratio is -3.63; Pulse Biosciences is scheduled to report earnings on November 9, 2023, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	$ -9.00K	$ 0.00	$ 265.00K
Gross Profit	-	-	$ -1.30M	$ -8.40M	$ -1.08M
EBIT	$ -9.91M	$ -9.80M	$ -8.74M	$ -18.02M	$ -14.01M
EBITDA	$ -9.61M	$ -9.50M	$ -8.39M	$ -17.69M	$ -13.66M
Net Income Common Stockholders	$ -9.91M	$ 9.32M	$ -9.20M	$ -18.04M	$ -14.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 58.75M	$ 54.10M	$ 61.14M	$ 69.16M	$ 14.80M
Total Assets	$ 74.76M	$ 70.22M	$ 77.88M	$ 87.57M	$ 40.60M
Total Debt	$ 9.62M	$ 75.63M	$ 10.96M	$ 75.34M	$ 10.45M
Net Debt	$ -49.13M	$ 21.54M	$ -50.18M	$ 6.18M	$ -4.35M
Total Liabilities	$ 14.26M	$ 80.89M	$ 80.13M	$ 81.38M	$ 17.18M
Stockholders Equity	$ 60.50M	$ -10.67M	$ -2.25M	$ 6.19M	$ 23.41M
Cash Flow	-
Free Cash Flow	$ -9.43M	$ -6.40M	$ -8.01M	$ -10.69M	$ -12.84M
Operating Cash Flow	$ -9.41M	$ -6.36M	$ -7.96M	$ -10.63M	$ -12.82M
Investing Cash Flow	$ -16.00K	$ -39.00K	$ -41.00K	$ -62.00K	$ -19.00K
Financing Cash Flow	$ 13.87M	$ -432.00K	$ -17.00K	$ 65.06M	$ 14.96M

Currency in USD

Pulse Biosciences Earnings and Revenue History

Income Statement >

Pulse Biosciences Debt to Assets

Balance Sheet >

Pulse Biosciences Cash Flow

Cash Flow >

Pulse Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing